RxDoctor Payments Data

Andrea Hill, MD

Obstetrics & Gynecology · South Charleston, WVNPI 1174552590

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Intuitive Surgical at 33.5% of the total. Reporting peaked in 2023 at $1,730 and has fallen 97.7% since, to $40 in 2025.

$3,440in general payments, 2019–2025

Across 115 payments — averaging $29.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • AbbVie$309
  • Aspira Women's Health Inc$289
  • Pfizer$280
  • Astellas Pharma US Inc$220
  • Myovant Sciences Inc.$163
  • plus $1K from 21 others

What the payments were for

  • Travel & lodging$1,15133%
  • Food & beverage$2,01258%
  • Education$2768%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,440 in reported general payments places this provider in the 80th percentile of 172 obstetrics & gynecology providers in West Virginia.

See all obstetrics & gynecology providers in West Virginia

Medicare billing

Part B allowed, 2024
$6,018
Medicare patients
57
Services billed
105

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide12$11,615
PremarinEstrogens, Conjugated14$6,016
Estradiol80$3,754
Estradiol (Twice Weekly)Estradiol13$1,827
Clobetasol Propionate17$506
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip17$417
Fluconazole34$164
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$280$6,01614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 172 obstetrics & gynecology providers in West Virginia.

Other obstetrics & gynecology in South Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →